| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ea05ed02f4992a8ad224b7bd0453370
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73df716a8c51a437e0abaf483bab7a75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f234846a4335071a83a8cf4db970f36e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71de593c287745f2c0eab81394f53978
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e5dce291e26911c319735f211429ac0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2010-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_341c4c1e463b5b09eb77690bcf035955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61f68589889f5872238b154e9cb72706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_043b9111bd3af7cdcf88273062207394
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7888c1648259c2fc5a73a61a53815cd |
| publicationDate |
2010-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010089330-A1 |
| titleOfInvention |
Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma |
| abstract |
Methods, devices and compositions for treatment of severe and uncontrolled asthma are provided by which high amounts of an inhaled corticosteroid are directed to the small airways of the lower lungs. The invention provides for a substantial decrease in the dose of concurrently administered oral corticosteroids. A particular advantage of the invention is the significant reduction in corticosteroid-related adverse effects. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3146990-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8807131-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014012954-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013132056-A1 |
| priorityDate |
2009-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |